Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 09-2010 | |
| Sales | 0 | 2,340 | 1,140 | 0 | 1,156,600 |
| Cost of Goods | N/A | N/A | N/A | N/A | 738,700 |
| Gross Profit | N/A | 2,340 | 1,140 | N/A | 417,900 |
| Operating Expenses | 219,263 | 121,739 | 127,081 | 0 | 372,700 |
| Operating Income | -219,263 | -119,399 | -125,941 | N/A | 45,900 |
| Interest Expense | 4,926 | 156 | 0 | 0 | 0 |
| Other Income | -21,774 | 3,653 | 3,069 | 0 | 39,700 |
| Pre-tax Income | -245,963 | -115,902 | -122,872 | 0 | 85,600 |
| Income Tax | 327 | 582 | 224 | N/A | 7,100 |
| Net Income Continuous | -246,290 | -116,484 | -123,096 | N/A | 78,500 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | -15,200 |
| Minority Interests | N/A | N/A | N/A | N/A | 1,300 |
| Net Income | $-246,290 | $-116,484 | $-123,096 | $N/A | $62,000 |
| EPS Basic Total Ops | -3.77 | -2.36 | -2.64 | N/A | 0.64 |
| EPS Basic Continuous Ops | -3.77 | -2.36 | -2.64 | N/A | 0.80 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | -0.16 |
| EPS Diluted Total Ops | -3.77 | -2.36 | -2.64 | N/A | 0.63 |
| EPS Diluted Continuous Ops | -3.77 | -2.36 | -2.64 | N/A | 0.78 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | -0.15 |
| EPS Diluted Before Non-Recurring Items | -3.77 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-217,075 | $-117,753 | $-125,201 | $N/A | $109,700 |